288 related articles for article (PubMed ID: 25200076)
41. Activation and inhibition of the AP-1 complex in human breast cancer cells.
Chen TK; Smith LM; Gebhardt DK; Birrer MJ; Brown PH
Mol Carcinog; 1996 Mar; 15(3):215-26. PubMed ID: 8597534
[TBL] [Abstract][Full Text] [Related]
42. Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer.
Li XF; Yan PJ; Shao ZM
Oncogene; 2009 Nov; 28(44):3937-48. PubMed ID: 19701247
[TBL] [Abstract][Full Text] [Related]
43. Re-expression of SPR1 in breast cancer cells by phorbol 12-myristate 13-acetate (PMA) or UV irradiation is mediated by the AP-1 binding site in the SPR1 promoter.
Anisowicz A; Sotiropoulou G; Sager R
Mol Med; 1999 Aug; 5(8):526-41. PubMed ID: 10501656
[TBL] [Abstract][Full Text] [Related]
44. TGFβ and EGF signaling orchestrates the AP-1- and p63 transcriptional regulation of breast cancer invasiveness.
Sundqvist A; Vasilaki E; Voytyuk O; Bai Y; Morikawa M; Moustakas A; Miyazono K; Heldin CH; Ten Dijke P; van Dam H
Oncogene; 2020 May; 39(22):4436-4449. PubMed ID: 32350443
[TBL] [Abstract][Full Text] [Related]
45. Plasminogen activator uPA is a direct transcriptional target of the JAG1-Notch receptor signaling pathway in breast cancer.
Shimizu M; Cohen B; Goldvasser P; Berman H; Virtanen C; Reedijk M
Cancer Res; 2011 Jan; 71(1):277-86. PubMed ID: 21199807
[TBL] [Abstract][Full Text] [Related]
46. siRNA-mediated simultaneous downregulation of uPA and its receptor inhibits angiogenesis and invasiveness triggering apoptosis in breast cancer cells.
Subramanian R; Gondi CS; Lakka SS; Jutla A; Rao JS
Int J Oncol; 2006 Apr; 28(4):831-9. PubMed ID: 16525631
[TBL] [Abstract][Full Text] [Related]
47. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.
Biermann JC; Holzscheiter L; Kotzsch M; Luther T; Kiechle-Bahat M; Sweep FC; Span PN; Schmitt M; Magdolen V
Int J Mol Med; 2008 Feb; 21(2):251-9. PubMed ID: 18204793
[TBL] [Abstract][Full Text] [Related]
48. Cholesterol sulfate stimulates involucrin transcription in keratinocytes by increasing Fra-1, Fra-2, and Jun D.
Hanley K; Wood L; Ng DC; He SS; Lau P; Moser A; Elias PM; Bikle DD; Williams ML; Feingold KR
J Lipid Res; 2001 Mar; 42(3):390-8. PubMed ID: 11254751
[TBL] [Abstract][Full Text] [Related]
49. Reversal of the hypomethylation status of urokinase (uPA) promoter blocks breast cancer growth and metastasis.
Pakneshan P; Szyf M; Farias-Eisner R; Rabbani SA
J Biol Chem; 2004 Jul; 279(30):31735-44. PubMed ID: 15150277
[TBL] [Abstract][Full Text] [Related]
50. Conversion of HPV 18 positive non-tumorigenic HeLa-fibroblast hybrids to invasive growth involves loss of TNF-alpha mediated repression of viral transcription and modification of the AP-1 transcription complex.
Soto U; Das BC; Lengert M; Finzer P; zur Hausen H; Rösl F
Oncogene; 1999 May; 18(21):3187-98. PubMed ID: 10359524
[TBL] [Abstract][Full Text] [Related]
51. Transcriptional regulation of urokinase (uPA) gene expression in breast cancer cells: role of DNA methylation.
Xing RH; Rabbani SA
Int J Cancer; 1999 May; 81(3):443-50. PubMed ID: 10209960
[TBL] [Abstract][Full Text] [Related]
52. MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1.
Yang S; Li Y; Gao J; Zhang T; Li S; Luo A; Chen H; Ding F; Wang X; Liu Z
Oncogene; 2013 Sep; 32(36):4294-303. PubMed ID: 23001043
[TBL] [Abstract][Full Text] [Related]
53. Galectin-3 modulates MUC2 mucin expression in human colon cancer cells at the level of transcription via AP-1 activation.
Song S; Byrd JC; Mazurek N; Liu K; Koo JS; Bresalier RS
Gastroenterology; 2005 Nov; 129(5):1581-91. PubMed ID: 16285957
[TBL] [Abstract][Full Text] [Related]
54. Demethylation of urokinase promoter as a prognostic marker in patients with breast carcinoma.
Pakneshan P; Têtu B; Rabbani SA
Clin Cancer Res; 2004 May; 10(9):3035-41. PubMed ID: 15131040
[TBL] [Abstract][Full Text] [Related]
55. Constitutive expression and regulation of collagenase-3 in human breast cancer cells.
Selvamurugan N; Partridge NC
Mol Cell Biol Res Commun; 2000 Apr; 3(4):218-23. PubMed ID: 10891395
[TBL] [Abstract][Full Text] [Related]
56. DEP-induced fra-1 expression correlates with a distinct activation of AP-1-dependent gene transcription in the lung.
Zhang Q; Kleeberger SR; Reddy SP
Am J Physiol Lung Cell Mol Physiol; 2004 Feb; 286(2):L427-36. PubMed ID: 14565943
[TBL] [Abstract][Full Text] [Related]
57. fra-2 promoter can respond to serum-stimulation through AP-1 complexes.
Sonobe MH; Yoshida T; Murakami M; Kameda T; Iba H
Oncogene; 1995 Feb; 10(4):689-96. PubMed ID: 7862446
[TBL] [Abstract][Full Text] [Related]
58. NCOA1 promotes angiogenesis in breast tumors by simultaneously enhancing both HIF1α- and AP-1-mediated VEGFa transcription.
Qin L; Xu Y; Xu Y; Ma G; Liao L; Wu Y; Li Y; Wang X; Wang X; Jiang J; Wang J; Xu J
Oncotarget; 2015 Sep; 6(27):23890-904. PubMed ID: 26287601
[TBL] [Abstract][Full Text] [Related]
59. Deciphering AP-1 function in tumorigenesis: fra-ternizing on target promoters.
Verde P; Casalino L; Talotta F; Yaniv M; Weitzman JB
Cell Cycle; 2007 Nov; 6(21):2633-9. PubMed ID: 17957143
[TBL] [Abstract][Full Text] [Related]
60. Mitogen regulated induction of FRA-1 proto-oncogene is controlled by the transcription factors binding to both serum and TPA response elements.
Adiseshaiah P; Peddakama S; Zhang Q; Kalvakolanu DV; Reddy SP
Oncogene; 2005 Jun; 24(26):4193-205. PubMed ID: 15806162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
